(Arg)8 Pep-LNP
Cat. No.: TDLD-0126-LD130
(Arg)8 Pep-LNP
(Arg)8 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) designed for efficient delivery of therapeutic cargoes. Featuring the (Arg)8 peptide, it enhances cellular uptake via R8-mediated endocytosis, offering improved stability for drug delivery systems. Applications include research on enhanced cargo delivery and cellular uptake mechanisms. Please note that this product is intended for research purposes only.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | (Arg)8 Peptide |
| LNP Type | Pep-LNP; Empty LNP; mRNA-LNP |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Click the button below to contact us or submit your feedback about this product.
